Alessia Muzi
A. Muzi And Dr. G. Roscilli Takis S.r.l, Via Castel Romano 100
Rome, 00128, Italy
Rome, 00128, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Synthesis and Biological Evaluation of a Novel Dual-Targeting Small Molecule Drug Conjugate Modulating the Crosstalk between α5β1 Integrin and MDM2 in Glioblastoma.
Journal: ACS medicinal chemistry letters
Published: November 06, 2025
Novel Humanized Anti-HER3 Antibodies: Structural Characterization and Therapeutic Activity.
Journal: Antibodies (Basel, Switzerland)
Published: July 03, 2025
Isolation and Characterization of Neutralizing Monoclonal Antibodies from a Large Panel of Murine Antibodies against RBD of the SARS-CoV-2 Spike Protein.
Journal: Antibodies (Basel, Switzerland)
Published: November 15, 2023
A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: October 21, 2022
A linear DNA encoding the SARS-CoV-2 receptor binding domain elicits potent immune response and neutralizing antibodies in domestic cats.
Journal: Molecular therapy. Methods & clinical development
Published: August 03, 2022
Persistent B cell memory after SARS-CoV-2 vaccination is functional during breakthrough infections.
Journal: Cell host & microbe
Published: November 17, 2021
The Nuts and Bolts of SARS-CoV-2 Spike Receptor-Binding Domain Heterologous Expression.
Journal: Biomolecules
Published: October 28, 2021
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 01, 2021
A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib.
Journal: Biochemical pharmacology
Published: February 16, 2015
Mutations of human DNA topoisomerase I at poly(ADP-ribose) binding sites: modulation of camptothecin activity by ADP-ribose polymers.
Journal: Journal of experimental & clinical cancer research : CR
Published: July 17, 2014
Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide.
Journal: BMC cancer
Published: October 15, 2013
Last Updated: 09/26/2026